⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30776494 | 1.00 | — | — | |
| SCHEMBL33525830 | 0.85 | — | — | |
| SCHEMBL33525908 | 0.78 | — | — | |
| SCHEMBL30776319 | 0.72 | — | — | |
| SCHEMBL33526097 | 0.71 | — | — | |
| SCHEMBL33526243 | 0.65 | — | — | |
| SCHEMBL24384545 | 0.62 | MAPT (0.40) | — | |
| SCHEMBL16418564 | 0.59 | — | — | |
| SCHEMBL24384671 | 0.56 | MAPT (0.42) | — | |
| SCHEMBL16418525 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043451-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY | 2024-02-08 | — | — | US | disclosed |
| WO-2023183585-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY (US) | 2023-09-28 | — | — | WO | disclosed |